AzTrials
AzTrials

Addiction, SubstanceNCT05794438

Gamified Adaptive Approach Bias Modification on Individuals With Methamphetamine Use History

A study testing Static Approach Bias Modification and Adaptive Approach Bias Modification in people with Addiction, Substance, run by Adai Technology (Beijing) Co., Ltd. at 12 sites in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A randomized controlled trial will be conducted to investigate whether a proposed algorithm that adjusts the congruency ratio based on the user's performance and difficulty can enhance the effectiveness of approach bias modification. Read more about this study

Who is it for?
Ages 18 to 55 years
Conditions the study is for
Addiction, Substance
What is being tested?
Static Approach Bias Modification and Adaptive Approach Bias Modification
Could I receive a placebo?
No, everyone receives an active treatment
How many people
139 participants
Where
12 sitesChina
Study dates
10 Mar 2023to 15 Jul 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • having a history of methamphetamine use of at least one year

Who cannot join

  • could not fluently operate an Android or an iOS smartphone
  • having mental health conditions other than MUD

Trial locations and contacts

12 sites in 1 country.

12 sites in 1 country

China12 sites
  • Gao Ping Town Community Drug Rehabilitation Center

    Luocheng, Sichuan

  • Han Zhou Street Community Drug Rehabilitation Center

    Luocheng, Sichuan

  • Jin Lun Town Community Drug Rehabilitation Center

    Luocheng, Sichuan

  • Jin Yan Street Community Drug Rehabilitation Center

    Luocheng, Sichuan

  • Jin Yu Town Community Drug Rehabilitation Center

    Luocheng, Sichuan

  • Lian Shan Town Community Drug Rehabilitation Center

    Luocheng, Sichuan

  • Nan Feng Town Community Drug Rehabilitation Center

    Luocheng, Sichuan

  • San Shui Town Community Drug Rehabilitation Center

    Luocheng, Sichuan

  • Sanxingdui Town Community Drug Rehabilitation Center

    Luocheng, Sichuan

  • SixTwentySix Service Center, Luo Cheng Street, Guanghan City

    Luocheng, Sichuan

  • Xiang Yang Town Community Drug Rehabilitation Center

    Luocheng, Sichuan

  • Xiao Han Town Community Drug Rehabilitation Center

    Luocheng, Sichuan

Other trials in China

About this study

A randomized controlled trial will be conducted to investigate whether a proposed algorithm that adjusts the congruency ratio based on the user's performance and difficulty can enhance the effectiveness of approach bias modification. Methamphetamine users will be recruited and randomized into an algorithm group, a standard group, and a control group.

Read the detailed description

To assess the efficacy of an adaptive approach bias modification (A-ApBM) paradigm with gamified designs and dynamic difficulty adjustments in reducing cue-induced craving in individuals with methamphetamine use history. DESIGN: Randomized controlled trial with three study groups: Adaptive ApBM (A-ApBM), Static ApBM (S-ApBM), and control. A-ApBM and S-ApBM groups engaged in ApBM training using a smartphone application for four weeks. A-ApBM used an adaptive algorithm to dynamically adjust the difficulty level based on individual performance, while S-ApBM had a static difficulty level. Cue-induced craving scores were assessed using a visual analog scale at baseline, post-intervention, and at week-16 follow-up.

Being tested
Static Approach Bias Modification, Adaptive Approach Bias Modification
Medical subject headings
Substance-Related Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Static Approach Bias ModificationBehavioural

    In the static approach bias modification, users were instructed to swipe upward when they see portrait format images and swipe downward when they see landscape format images. A shrinking animation comes after swiping upward to simulate the visual effect of moving away (approach), and a growing animation comes after swiping downward to simulate the visual effect of moving towards (avoidance). Two types of images, namely drug-related and non-drug-related, were used in the training. The drug-related images were related to methamphetamine (methamphetamine crystals, powders, and paraphernalia), and the non-drug-related images were related to healthy lifestyles (wealth, sports, gourmet, family activities, etc).

  • Adaptive Approach Bias ModificationBehavioural

    In the adaptive approach bias modification, users were instructed to swipe upward when they see portrait format images and swipe downward when they see landscape format images. A shrinking animation comes after swiping upward to simulate the visual effect of moving away (approach), and a growing animation comes after swiping downward to simulate the visual effect of moving towards (avoidance). Two types of images, namely drug-related and non-drug-related, were used in the training. The drug-related images were related to methamphetamine (methamphetamine crystals, powders, and paraphernalia), and the non-drug-related images were related to healthy lifestyles (wealth, sports, gourmet, family activities, etc). An algorithm continuously monitors the performance of the user and adjusts the ratio of congruent and incongruent trials accordingly to attain a desired difficulty curve.

Study groups in NCT05794438
Study groupRoleWhat they receive
Adaptive Approach Bias ModificationExperimentalNot described
Receives: Behavioral: Adaptive Approach Bias Modification
Static Approach Bias ModificationExperimentalNot described
Receives: Behavioral: Static Approach Bias Modification
ControlNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cue induced craving for methamphetamine

    The cue-induced craving was assessed by showing the participants images related to methamphetamine (methamphetamine crystals, powders, and paraphernalia) on a smartphone and asking them to rate their cravings on a 0-10 visual analog scale (0 being least craved and 10 being most craved).

    Measured: Baseline

  2. Cue induced craving for methamphetamine

    The cue-induced craving was assessed by showing the participants images related to methamphetamine (methamphetamine crystals, powders, and paraphernalia) on a smartphone and asking them to rate their cravings on a 0-10 visual analog scale (0 being least craved and 10 being most craved).

    Measured: Immediately Post-intervention

  3. Cue induced craving for methamphetamine

    The cue-induced craving was assessed by showing the participants images related to methamphetamine (methamphetamine crystals, powders, and paraphernalia) on a smartphone and asking them to rate their cravings on a 0-10 visual analog scale (0 being least craved and 10 being most craved).

    Measured: 16 week from baseline assesment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Apr 2023
  2. Study start10 Mar 2023
  3. Primary completion15 Jul 2023
  4. Study completion15 Jul 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
139 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05794438
Sponsor's protocol ID
TS001
Status last verified
Jul 2023
First submitted
6 Mar 2023
Last updated
18 Jul 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Static Approach Bias Modification and Adaptive Approach Bias Modification in people with Addiction, Substance, run by Adai Technology (Beijing) Co., Ltd. at 12 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 12 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cue induced craving for methamphetamine (time frame: Baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jul 2023; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in